COPD

Recent Updates and Role of Chronic Disease Management and Protocolized Management

Zafirah Salman, Matthew M. Nobari, David Tybor, Babar Khan, Khalil Diab

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The annual cost of chronic obstructive pulmonary disease (COPD) in the United States in 2008 was $53.7 billion, largely due to visits to a medical facility for exacerbations. In this article, we explore the most recent updates on the medical management of COPD, including the most recently released inhalers. We also explore the role of COPD self-management and integrated disease management, and discuss the most recent studies pertaining to those. In addition, we discuss the most recent updates on bronchoscopic interventions for lung volume reduction. We also discuss the results of our study assessing the role of protocolized COPD management on the basis of Global Chronic Obstructive Lung Disease guidelines and its effects on COPD exacerbation rates, quality of life, and depression scores.

Original languageEnglish (US)
Pages (from-to)170-175
Number of pages6
JournalClinical Pulmonary Medicine
Volume24
Issue number4
DOIs
StatePublished - 2017

Fingerprint

Disease Management
Chronic Obstructive Pulmonary Disease
Chronic Disease
Pneumonectomy
Nebulizers and Vaporizers
Self Care
Disease Progression
Quality of Life
Guidelines
Costs and Cost Analysis

Keywords

  • chronic obstructive airway disease
  • chronic obstructive lung disease
  • pulmonary disease, chronic obstructive

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

COPD : Recent Updates and Role of Chronic Disease Management and Protocolized Management. / Salman, Zafirah; Nobari, Matthew M.; Tybor, David; Khan, Babar; Diab, Khalil.

In: Clinical Pulmonary Medicine, Vol. 24, No. 4, 2017, p. 170-175.

Research output: Contribution to journalArticle

Salman, Zafirah ; Nobari, Matthew M. ; Tybor, David ; Khan, Babar ; Diab, Khalil. / COPD : Recent Updates and Role of Chronic Disease Management and Protocolized Management. In: Clinical Pulmonary Medicine. 2017 ; Vol. 24, No. 4. pp. 170-175.
@article{95457835bea3417ca718fafbe80adaab,
title = "COPD: Recent Updates and Role of Chronic Disease Management and Protocolized Management",
abstract = "The annual cost of chronic obstructive pulmonary disease (COPD) in the United States in 2008 was $53.7 billion, largely due to visits to a medical facility for exacerbations. In this article, we explore the most recent updates on the medical management of COPD, including the most recently released inhalers. We also explore the role of COPD self-management and integrated disease management, and discuss the most recent studies pertaining to those. In addition, we discuss the most recent updates on bronchoscopic interventions for lung volume reduction. We also discuss the results of our study assessing the role of protocolized COPD management on the basis of Global Chronic Obstructive Lung Disease guidelines and its effects on COPD exacerbation rates, quality of life, and depression scores.",
keywords = "chronic obstructive airway disease, chronic obstructive lung disease, pulmonary disease, chronic obstructive",
author = "Zafirah Salman and Nobari, {Matthew M.} and David Tybor and Babar Khan and Khalil Diab",
year = "2017",
doi = "10.1097/CPM.0000000000000219",
language = "English (US)",
volume = "24",
pages = "170--175",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - COPD

T2 - Recent Updates and Role of Chronic Disease Management and Protocolized Management

AU - Salman, Zafirah

AU - Nobari, Matthew M.

AU - Tybor, David

AU - Khan, Babar

AU - Diab, Khalil

PY - 2017

Y1 - 2017

N2 - The annual cost of chronic obstructive pulmonary disease (COPD) in the United States in 2008 was $53.7 billion, largely due to visits to a medical facility for exacerbations. In this article, we explore the most recent updates on the medical management of COPD, including the most recently released inhalers. We also explore the role of COPD self-management and integrated disease management, and discuss the most recent studies pertaining to those. In addition, we discuss the most recent updates on bronchoscopic interventions for lung volume reduction. We also discuss the results of our study assessing the role of protocolized COPD management on the basis of Global Chronic Obstructive Lung Disease guidelines and its effects on COPD exacerbation rates, quality of life, and depression scores.

AB - The annual cost of chronic obstructive pulmonary disease (COPD) in the United States in 2008 was $53.7 billion, largely due to visits to a medical facility for exacerbations. In this article, we explore the most recent updates on the medical management of COPD, including the most recently released inhalers. We also explore the role of COPD self-management and integrated disease management, and discuss the most recent studies pertaining to those. In addition, we discuss the most recent updates on bronchoscopic interventions for lung volume reduction. We also discuss the results of our study assessing the role of protocolized COPD management on the basis of Global Chronic Obstructive Lung Disease guidelines and its effects on COPD exacerbation rates, quality of life, and depression scores.

KW - chronic obstructive airway disease

KW - chronic obstructive lung disease

KW - pulmonary disease, chronic obstructive

UR - http://www.scopus.com/inward/record.url?scp=85021814634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021814634&partnerID=8YFLogxK

U2 - 10.1097/CPM.0000000000000219

DO - 10.1097/CPM.0000000000000219

M3 - Article

VL - 24

SP - 170

EP - 175

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 4

ER -